
Molecular Biology Enzymes and Kits & Reagents Market based on by Product (Kits and Reagents, Enzymes, Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases, Others), by Application (Polymerase Chain Reaction, Sequencing, Cloning, Epigen
Description
Gene mutations are significant in the aetiology and progression of illnesses and disorders such as immune system disorders, metabolic diseases, cancer, and in-born genetic disorders. As a result, researchers may use extensive knowledge of the human genome to better understand the aetiology of certain disorders and devise treatment regimens. The growing number of genome projects throughout the world, along with lower genetic analysis costs, aids in the advancement of research in areas such as illness treatment, personalised medicine, and microbial genetics. These procedures necessitate the employment of numerous molecular biology enzymes and reagents, and as a result, the molecular biology enzymes and kits & reagents market is predicted to grow.
Genomic research has grown as a scientific study subject during the last two decades. The genomics sector has seen major technical advances as a result of grants and financing from government entities. R&D investments have given chances for expansion in the molecular biology enzymes and kits & reagents markets. China is one of the world's top R&D investors, with the country likely to surpass the United States in R&D spending by 2023 (Source: Council on Foreign Relations or CFR). As a result, several corporations have expanded their operations and R&D efforts in China. In 2020, the country's R&D investment is expected to increase from 10.3% to USD 378 billion (2.44 trillion Chinese yuan).
However, reimbursement regulations for genetic testing are rigid. Unless authorised by a physician, most health insurance plans in the United States do not cover the cost of genetic testing. Coverage and reimbursement are completely determined by the provider's policy. For example, Medicare covers genetic testing for persons with cancer who qualify for Medicare coverage of genetic testing for an inherited mutation. Such worries are stifling market expansion throughout the world.
The segmentation coverage of the study is provided below.
Molecular Biology Enzymes and Kits & Reagents Market based on Product
Previously, North America led the worldwide Molecular Biology Enzymes, Kits, and Reagents market, with Europe close behind. Factors contributing to North American market domination include the availability of cutting-edge technology and the presence of better research institutes for R&D on enzymes and reagents. However, the expanding number of life science and drug discovery research, as well as important improvements in health and medicine in emerging nations, are expected to assist Asia Pacific grow significantly throughout the projection period.
The competitive landscape for molecular biology kits and reagents gives information by competitor. Company overview, financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance are all included. The data points shown above are only linked to the firms' concentration on the molecular biology kits and reagent sector.
Thermo Fisher Scientific, Inc., LGC Limited, Merck KGaA, Promega Corporation, New England Biolabs, Illumina, Inc., Takara Bio Inc., Qiagen, FUJIFILM, and others are among the prominent competitors profiled in the molecular biology kits and reagent market research. Among the local and worldwide companies are Wako Pure Chemical Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Sigma-Aldrich Co., Bio-Rad Laboratories, Inc., Bio Basic Inc., Jena Bioscience GmbH, BD, Abbott, Beckman Coulter, Inc., Life Technologies, and MBR, Inc. Global, North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America market share statistics are accessible individually. Analysts at DBMR evaluate competitive strengths and conduct competitive analysis for each rival individually.
Genomic research has grown as a scientific study subject during the last two decades. The genomics sector has seen major technical advances as a result of grants and financing from government entities. R&D investments have given chances for expansion in the molecular biology enzymes and kits & reagents markets. China is one of the world's top R&D investors, with the country likely to surpass the United States in R&D spending by 2023 (Source: Council on Foreign Relations or CFR). As a result, several corporations have expanded their operations and R&D efforts in China. In 2020, the country's R&D investment is expected to increase from 10.3% to USD 378 billion (2.44 trillion Chinese yuan).
However, reimbursement regulations for genetic testing are rigid. Unless authorised by a physician, most health insurance plans in the United States do not cover the cost of genetic testing. Coverage and reimbursement are completely determined by the provider's policy. For example, Medicare covers genetic testing for persons with cancer who qualify for Medicare coverage of genetic testing for an inherited mutation. Such worries are stifling market expansion throughout the world.
The segmentation coverage of the study is provided below.
Molecular Biology Enzymes and Kits & Reagents Market based on Product
- Kits and Reagents
- Enzymes
- Polymerases
- Ligases
- Restriction Endonucleases
- Reverse Transcriptases
- Others
- Polymerase Chain Reaction
- Sequencing
- Cloning
- Epigenetics
- Restriction Digestion
- Synthetic Biology
- Others
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Centers
- Others
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Previously, North America led the worldwide Molecular Biology Enzymes, Kits, and Reagents market, with Europe close behind. Factors contributing to North American market domination include the availability of cutting-edge technology and the presence of better research institutes for R&D on enzymes and reagents. However, the expanding number of life science and drug discovery research, as well as important improvements in health and medicine in emerging nations, are expected to assist Asia Pacific grow significantly throughout the projection period.
The competitive landscape for molecular biology kits and reagents gives information by competitor. Company overview, financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance are all included. The data points shown above are only linked to the firms' concentration on the molecular biology kits and reagent sector.
Thermo Fisher Scientific, Inc., LGC Limited, Merck KGaA, Promega Corporation, New England Biolabs, Illumina, Inc., Takara Bio Inc., Qiagen, FUJIFILM, and others are among the prominent competitors profiled in the molecular biology kits and reagent market research. Among the local and worldwide companies are Wako Pure Chemical Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Sigma-Aldrich Co., Bio-Rad Laboratories, Inc., Bio Basic Inc., Jena Bioscience GmbH, BD, Abbott, Beckman Coulter, Inc., Life Technologies, and MBR, Inc. Global, North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America market share statistics are accessible individually. Analysts at DBMR evaluate competitive strengths and conduct competitive analysis for each rival individually.
- This report illustrates the most vital attributes of the Molecular Biology Enzymes and Kits & Reagents Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Molecular Biology Enzymes and Kits & Reagents Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Molecular Biology Enzymes and Kits & Reagents Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Molecular Biology Enzymes and Kits & Reagents Market.
Table of Contents
160 Pages
- 1. Executive Summary
- 2. Industry Outlook
- 2.1. Industry Overview
- 2.2. Industry Trends
- 3. Market Snapshot
- 3.1. Market Definition
- 3.2. Market Outlook
- 3.2.1. Porter Five Forces
- 3.3. Related Markets
- 4. Market characteristics
- 4.1. Market Overview
- 4.2. Market Segmentation
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. DRO - Impact Analysis
- 5. Product: Market Size & Analysis
- 5.1. Overview
- 5.2. Kits and Reagents
- 5.3. Enzymes
- 5.4. Polymerases
- 5.5. Ligases
- 5.6. Restriction Endonucleases
- 5.7. Reverse Transcriptases
- 5.8. Others
- 6. Application: Market Size & Analysis
- 6.1. Overview
- 6.2. Polymerase Chain Reaction
- 6.3. Sequencing
- 6.4. Cloning
- 6.5. Epigenetics
- 6.6. Restriction Digestion
- 6.7. Synthetic Biology
- 6.8. Others
- 7. End User: Market Size & Analysis
- 7.1. Overview
- 7.2. Academic and Research Institutes
- 7.3. Pharmaceutical and Biotechnology Companies
- 7.4. Hospitals and Diagnostic Centers
- 7.5. Others
- 8. Geography: Market Size & Analysis
- 8.1. Overview
- 8.2. North America (U.S., Mexico, Canada)
- 8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
- 8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
- 8.5. Latin America (Brazil, Argentina)
- 8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
- 9. Competitive Landscape
- 9.1. Competitor Comparison Analysis
- 9.2. Market Developments
- 9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
- 9.2.2. Product Launches and execution
- 10. Vendor Profiles
- 10.1. LGC LIMITED
- 10.1.1. Overview
- 10.1.2. Financial Overview
- 10.1.3. Product Offerings
- 10.1.4. Developments
- 10.1.5. Business Strategy
- 10.2. PROMEGA CORPORATION
- 10.2.1. Overview
- 10.2.2. Financial Overview
- 10.2.3. Product Offerings
- 10.2.4. Developments
- 10.2.5. Business Strategy
- 10.3. MERCK KGAA
- 10.3.1. Overview
- 10.3.2. Financial Overview
- 10.3.3. Product Offerings
- 10.3.4. Developments
- 10.3.5. Business Strategy
- 10.4. NEW ENGLAND BIOLABS
- 10.4.1. Overview
- 10.4.2. Financial Overview
- 10.4.3. Product Offerings
- 10.4.4. Developments
- 10.4.5. Business Strategy
- 10.5. ILLUMINA INC.
- 10.5.1. Overview
- 10.5.2. Financial Overview
- 10.5.3. Product Offerings
- 10.5.4. Developments
- 10.5.5. Business Strategy
- 10.6. TAKARA BIO INC.
- 10.6.1. Overview
- 10.6.2. Financial Overview
- 10.6.3. Product Offerings
- 10.6.4. Developments
- 10.6.5. Business Strategy
- 10.7. BIO-RAD LABORATORIES INC.
- 10.7.1. Overview
- 10.7.2. Financial Overview
- 10.7.3. Product Offerings
- 10.7.4. Developments
- 10.7.5. Business Strategy
- 10.8. THERMO FISHER SCIENTIFIC, INC.
- 10.8.1. Overview
- 10.8.2. Financial Overview
- 10.8.3. Product Offerings
- 10.8.4. Developments
- 10.8.5. Business Strategy
- 10.9. F.HOFFMANN-LA ROCHE LTD.
- 10.9.1. Overview
- 10.9.2. Financial Overview
- 10.9.3. Product Offerings
- 10.9.4. Developments
- 10.9.5. Business Strategy
- 10.10. QIAGEN
- 10.10.1. Overview
- 10.10.2. Financial Overview
- 10.10.3. Product Offerings
- 10.10.4. Developments
- 10.10.5. Business Strategy
- 11. Analyst Opinion
- 12. Annexure
- 12.1. Report Scope
- 12.2. Market Definitions
- 12.3. Research Methodology
- 12.3.1. Data Collation and In-house Estimation
- 12.3.2. Market Triangulation
- 12.3.3. Forecasting
- 12.4. Report Assumptions
- 12.5. Declarations
- 12.6. Stakeholders
- 12.7. Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.